Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma

Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma

  • CN 1,270,774 C
  • Filed: 11/12/1993
  • Issued: 08/23/2006
  • Est. Priority Date: 11/13/1992
  • Status: Active Grant
First Claim
Patent Images

1. the application of the chimeric anti-CD 20 antibodies of immunocompetence in the medicine of preparation treatment B cell lymphoma, described chimeric anti-CD 20 antibodies has variable heavy chain sequence shown in Figure 5 and variable sequence of light chain and human IgG1'"'"'s constant region shown in Figure 4.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×